tiprankstipranks
Trending News
More News >
Ascletis Pharma, Inc. (HK:1672)
:1672
Hong Kong Market

Compare Ascletis Pharma, Inc. (1672) vs. Competitors

Compare
8 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Ascletis Pharma, Inc.
HK$12.33
HK$13.69B
-48.42
240.74%
1 Buy
0 Hold
0 Sell
Moderate Buy
Lepu Biopharma Co. Ltd. Class H
HK$4.98
HK$8.66B
-41.39
70.70%
CARsgen Therapeutics Holdings Ltd.
HK$14.89
HK$8.96B
-15.59
53.77%
1 Buy
0 Hold
0 Sell
Moderate Buy
Jiangsu Recbio Technology Co., Ltd. Class H
HK$4.18
HK$2.40B
-3.40
-39.57%
Shanghai Henlius Biotech, Inc. Class H
HK$58.60
HK$31.14B
34.99
241.89%
Shandong Boan Biotechnology Company., Limited. Class H
HK$8.33
HK$5.18B
134.79
-4.25%

Performance Comparison

Ticker
Company Name
Price
Change
% Change
HK:1672
Ascletis Pharma, Inc.
13.80
9.79
244.14%
HK:2157
Lepu Biopharma Co. Ltd. Class H
4.66
1.77
61.25%
HK:2171
CARsgen Therapeutics Holdings Ltd.
15.50
5.42
53.77%
HK:2179
Jiangsu Recbio Technology Co., Ltd. Class H
5.01
-3.34
-40.00%
HK:2696
Shanghai Henlius Biotech, Inc. Class H
57.30
40.32
237.46%
HK:6955
Shandong Boan Biotechnology Company., Limited. Class H
8.33
-0.37
-4.25%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts